A study examining mRNA expression profiles of liver tissue samples derived from patients with HCC and those with cirrhosis of various etiologies (including HBV and HCV infection) had reported that the downregulation of C9 could be considered as a cancer associated molecular signature in premalignant cirrhotic tissues and may serve as an early diagnostic marker for the onset of HCC [22]. This evidence concerns the gene C9 and cancer.